tiprankstipranks
Trending News
More News >
Takeda Pharmaceutical Company (TAK)
NYSE:TAK

Takeda Pharmaceutical Company (TAK) Revenue

Compare
1,347 Followers

Takeda Pharmaceutical Company Revenue

Takeda Pharmaceutical Company had a revenue of 1.21T in the quarter ending Dec 31, 2025, with 9.02%. This bring the company's revenue in the last twelve months to 4.49T, Decreased 1.56%. In the fiscal year ending Mar 31, 2025, Takeda Pharmaceutical Company had annual revenue of 4.58T with 7.45% growth.
Revenue (ttm)
4.49T
Revenue Growth
-1.98%
P/S Ratio
0.01
Revenue/Employee
$92,967,898
Employees
49,281
Market Cap
$58.30B

Revenue Chart

Revenue History
Fiscal End Date
Revenue
Change
Growth
Mar 31, 2025
4.58T317.79B+7.45%
Mar 31, 2024
4.26T236.28B+5.87%
Mar 31, 2023
4.03T458.47B+12.85%
Mar 31, 2022
3.57T371.19B+11.61%
Mar 31, 2021
3.20T-93.38B-2.84%
Mar 31, 2020
3.29T1.19T+56.93%
Mar 31, 2019
2.10T326.69B+18.45%
Mar 31, 2018
1.77T